Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Evidence for waning of latency in a cohort study of tuberculosis

Authors: Harald G Wiker, Tehmina Mustafa, Gunnar A Bjune, Morten Harboe

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

To investigate how the risk of active tuberculosis disease is influenced by time since original infection and to determine whether the risk of reactivation of tuberculosis increases or decreases with age.

Methods

Cohort analysis of data for the separate ten year birth cohorts of 1876-1885 to 1959-1968 obtained from Statistics Norway and the National Tuberculosis Registry. These data were used to calculate the rates and the changes in the rates of bacillary (or active) tuberculosis. Data on bacillary tuberculosis for adult (20+) age groups were obtained from the National Tuberculosis Registry and Statistics Norway from 1946 to 1974. Most cases during this period arose due to reactivation of remote infection. Participants in this part of the analysis were all reported active tuberculosis cases in Norway from 1946 to 1974 as recorded in the National Tuberculosis Registry.

Results

Tuberculosis decreased at a relatively steady rate when following individual birth cohorts, but with a tendency of slower decline as time passed since infection. A mean estimate of this rate of decline was 57% in a 10 year period.

Conclusions

The risk of reactivation of latent tuberculosis decreases with age. This decline may reflect the rate at which latent tuberculosis is eliminated from a population with minimal transmission of tubercle bacilli. A model for risk of developing active tuberculosis as a function of time since infection shows that the rate at which tuberculosis can be eliminated from a society can be quite substantial if new infections are effectively prevented. The findings clearly indicate that preventative measures against transmission of tuberculosis will be the most effective. These results also suggest that the total population harbouring live tubercle bacilli and consequently the future projection for increased incidence of tuberculosis in the world is probably overestimated.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sterling TR: New approaches to the treatment of latent tuberculosis. Semin Respir Crit Care Med. 2008, 29: 532-541. 10.1055/s-0028-1085704.CrossRefPubMed Sterling TR: New approaches to the treatment of latent tuberculosis. Semin Respir Crit Care Med. 2008, 29: 532-541. 10.1055/s-0028-1085704.CrossRefPubMed
2.
go back to reference Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970, 26: 28-106.PubMed Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970, 26: 28-106.PubMed
3.
go back to reference Parrish NM, Dick JD, Bishai WR: Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 1998, 6: 107-112. 10.1016/S0966-842X(98)01216-5.CrossRefPubMed Parrish NM, Dick JD, Bishai WR: Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 1998, 6: 107-112. 10.1016/S0966-842X(98)01216-5.CrossRefPubMed
4.
go back to reference Pai M, O'Brien R: New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin Respir Crit Care Med. 2008, 29: 560-568. 10.1055/s-0028-1085707.CrossRefPubMed Pai M, O'Brien R: New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin Respir Crit Care Med. 2008, 29: 560-568. 10.1055/s-0028-1085707.CrossRefPubMed
5.
go back to reference Opie EL, Aronson JD: Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med. 1927, 4: 1-21. Opie EL, Aronson JD: Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med. 1927, 4: 1-21.
6.
go back to reference Balasubramanian V, Wiegeshaus EH, Taylor BT, Smith DW: Pathogenesis of tuberculosis: pathway to apical localization. Tuber Lung Dis. 1994, 75: 168-178. 10.1016/0962-8479(94)90002-7.CrossRefPubMed Balasubramanian V, Wiegeshaus EH, Taylor BT, Smith DW: Pathogenesis of tuberculosis: pathway to apical localization. Tuber Lung Dis. 1994, 75: 168-178. 10.1016/0962-8479(94)90002-7.CrossRefPubMed
7.
go back to reference Hernandez-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook GAW, Bjune G: Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet. 2000, 356: 2133-2138. 10.1016/S0140-6736(00)03493-0.CrossRefPubMed Hernandez-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook GAW, Bjune G: Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet. 2000, 356: 2133-2138. 10.1016/S0140-6736(00)03493-0.CrossRefPubMed
8.
go back to reference Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VØ: Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis. 2002, 185: 401-404. 10.1086/338342.CrossRefPubMed Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VØ: Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis. 2002, 185: 401-404. 10.1086/338342.CrossRefPubMed
9.
go back to reference Lillebaek T, Dirksen A, Vynnycky E, Baess I, Thomsen VØ, Andersen AB: Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection. J Infect Dis. 2003, 188: 1032-1039. 10.1086/378240.CrossRefPubMed Lillebaek T, Dirksen A, Vynnycky E, Baess I, Thomsen VØ, Andersen AB: Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection. J Infect Dis. 2003, 188: 1032-1039. 10.1086/378240.CrossRefPubMed
10.
go back to reference Lin MY, Ottenhoff TH: Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention. Endocr Metab Immune Disord Drug Targets. 2008, 8: 15-29. 10.2174/187153008783928398.CrossRefPubMed Lin MY, Ottenhoff TH: Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention. Endocr Metab Immune Disord Drug Targets. 2008, 8: 15-29. 10.2174/187153008783928398.CrossRefPubMed
11.
go back to reference Borgdorff MW, Werf van der MJ, de Haas PE, Kremer K, van Soolingen D: Tuberculosis elimination in the Netherlands. Emerg Infect Dis. 2005, 11: 597-602.CrossRefPubMedPubMedCentral Borgdorff MW, Werf van der MJ, de Haas PE, Kremer K, van Soolingen D: Tuberculosis elimination in the Netherlands. Emerg Infect Dis. 2005, 11: 597-602.CrossRefPubMedPubMedCentral
12.
go back to reference Bjartveit K: [Article in Norwegian][Situation of tuberculosis in Norway]. Tidsskr Nor Laegeforen. 1975, 95: 1049-1055.PubMed Bjartveit K: [Article in Norwegian][Situation of tuberculosis in Norway]. Tidsskr Nor Laegeforen. 1975, 95: 1049-1055.PubMed
13.
go back to reference Dahl E, Backer J: [Article in Norwegian][Tuberculosis in Oslo during the war]. Nor Mag Laegevid. 1945, 108: 2305-2313. Dahl E, Backer J: [Article in Norwegian][Tuberculosis in Oslo during the war]. Nor Mag Laegevid. 1945, 108: 2305-2313.
14.
go back to reference Dahle UR, Sandven P, Heldal E, Caugant DA: Continued low rates of transmission of Mycobacterium tuberculosis in Norway. J Clin Microbiol. 2003, 41: 2968-2973. 10.1128/JCM.41.7.2968-2973.2003.CrossRefPubMedPubMedCentral Dahle UR, Sandven P, Heldal E, Caugant DA: Continued low rates of transmission of Mycobacterium tuberculosis in Norway. J Clin Microbiol. 2003, 41: 2968-2973. 10.1128/JCM.41.7.2968-2973.2003.CrossRefPubMedPubMedCentral
15.
go back to reference Dahle UR, Sandven P, Heldal E, Caugant DA: Molecular epidemiology of Mycobacterium tuberculosis in Norway. J Clin Microbiol. 2001, 39: 1802-1807. 10.1128/JCM.39.5.1802-1807.2001.CrossRefPubMedPubMedCentral Dahle UR, Sandven P, Heldal E, Caugant DA: Molecular epidemiology of Mycobacterium tuberculosis in Norway. J Clin Microbiol. 2001, 39: 1802-1807. 10.1128/JCM.39.5.1802-1807.2001.CrossRefPubMedPubMedCentral
16.
go back to reference Bandera A, Gori A, Catozzi L, Degli EA, Marchetti G, Molteni C, Ferrario G, Codecasa L, Penati V, Mateelli A, Franzetti F: Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol. 2001, 39: 2213-2218. 10.1128/JCM.39.6.2213-2218.2001.CrossRefPubMedPubMedCentral Bandera A, Gori A, Catozzi L, Degli EA, Marchetti G, Molteni C, Ferrario G, Codecasa L, Penati V, Mateelli A, Franzetti F: Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol. 2001, 39: 2213-2218. 10.1128/JCM.39.6.2213-2218.2001.CrossRefPubMedPubMedCentral
17.
go back to reference Andvord KF: [Original article in Norwegian][What can we learn by following the development of tuberculosis from one generation to another?]. Nor Mag Laegevid. 1930, 91: 642-660. Andvord KF: [Original article in Norwegian][What can we learn by following the development of tuberculosis from one generation to another?]. Nor Mag Laegevid. 1930, 91: 642-660.
18.
go back to reference Andvord KF: [Translation of original article published in 1930][What can we learn by following the development of tuberculosis from one generation to another?]. Int J Tuberc Lung Dis. 2002, 6: 562-568.PubMed Andvord KF: [Translation of original article published in 1930][What can we learn by following the development of tuberculosis from one generation to another?]. Int J Tuberc Lung Dis. 2002, 6: 562-568.PubMed
19.
go back to reference Blomberg B, Rieder HL, Enarson DA: Kristian Andvord's impact on the understanding of tuberculosis epidemiology. Int J Tuberc Lung Dis. 2002, 6: 557-559.PubMed Blomberg B, Rieder HL, Enarson DA: Kristian Andvord's impact on the understanding of tuberculosis epidemiology. Int J Tuberc Lung Dis. 2002, 6: 557-559.PubMed
20.
go back to reference Haider T, Tverdal A: [Article in Norwegian][Prevalence of tuberculosis infections]. Tidsskr Nor Laegeforen. 1982, 102: 1065-1068.PubMed Haider T, Tverdal A: [Article in Norwegian][Prevalence of tuberculosis infections]. Tidsskr Nor Laegeforen. 1982, 102: 1065-1068.PubMed
21.
go back to reference Sandberg HK: [Article in Norwegian][Register of tuberculin test results and decrease in tuberculosis; indications for continuing present control procedures]. Tidsskr Nor Laegeforen. 1954, 74: 317-322.PubMed Sandberg HK: [Article in Norwegian][Register of tuberculin test results and decrease in tuberculosis; indications for continuing present control procedures]. Tidsskr Nor Laegeforen. 1954, 74: 317-322.PubMed
22.
go back to reference Comstock GW: Frost revisited: the modern epidemiology of tuberculosis. Am J Epidemiol. 1975, 101: 363-382.PubMed Comstock GW: Frost revisited: the modern epidemiology of tuberculosis. Am J Epidemiol. 1975, 101: 363-382.PubMed
23.
go back to reference France AM, Cave MD, Bates JH, Foxman B, Chu T, Yana Z: What's driving the decline in tuberculosis in Arkansas? A molecular epidemiologic analysis of tuberculosis trends in a rural, low-incidence population, 1997-2003. Am J Epidemiol. 2007, 166: 662-671. 10.1093/aje/kwm135.CrossRefPubMed France AM, Cave MD, Bates JH, Foxman B, Chu T, Yana Z: What's driving the decline in tuberculosis in Arkansas? A molecular epidemiologic analysis of tuberculosis trends in a rural, low-incidence population, 1997-2003. Am J Epidemiol. 2007, 166: 662-671. 10.1093/aje/kwm135.CrossRefPubMed
24.
go back to reference Grzybowski S, Allen EA: The challenge of tuberculosis in decline. A study on the epidemiology of tuberculosis in Ontario, Canada. Am Rev Respir Dis. 1964, 90: 707-720.PubMed Grzybowski S, Allen EA: The challenge of tuberculosis in decline. A study on the epidemiology of tuberculosis in Ontario, Canada. Am Rev Respir Dis. 1964, 90: 707-720.PubMed
25.
go back to reference Mori T, Harada N, Higuchi K, Sekiya Y, Uchimura K, Shimao T: Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc Lung Dis. 2007, 11: 1021-1025.PubMed Mori T, Harada N, Higuchi K, Sekiya Y, Uchimura K, Shimao T: Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc Lung Dis. 2007, 11: 1021-1025.PubMed
26.
go back to reference Tocque K, Bellis MA, Tam CM, Chan SL, Syed Q, Remmington T, Davies PD: Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales. Am J Respir Crit Care Med. 1998, 158: 484-488.CrossRefPubMed Tocque K, Bellis MA, Tam CM, Chan SL, Syed Q, Remmington T, Davies PD: Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales. Am J Respir Crit Care Med. 1998, 158: 484-488.CrossRefPubMed
27.
go back to reference Fine PE, Small PM: Exogenous reinfection in tuberculosis. N Engl J Med. 1999, 341: 1226-1227. 10.1056/NEJM199910143411609.CrossRefPubMed Fine PE, Small PM: Exogenous reinfection in tuberculosis. N Engl J Med. 1999, 341: 1226-1227. 10.1056/NEJM199910143411609.CrossRefPubMed
28.
go back to reference van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, Beyers N, van Elden PD: Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999, 341: 1174-1179. 10.1056/NEJM199910143411602.CrossRefPubMed van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, Beyers N, van Elden PD: Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999, 341: 1174-1179. 10.1056/NEJM199910143411602.CrossRefPubMed
29.
go back to reference Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, Gey van Pittius NC, van Elden PD: Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med. 2004, 169: 610-614. 10.1164/rccm.200305-714OC.CrossRefPubMed Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, Gey van Pittius NC, van Elden PD: Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med. 2004, 169: 610-614. 10.1164/rccm.200305-714OC.CrossRefPubMed
30.
go back to reference Victor TC, Streicher EM, Kewley C, Jordaan AM, Spuy van der GD, Bosman M, Louw H, Murray M, Young D, van Helden PD, Warren RM: Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis. 2007, 11: 195-201.PubMed Victor TC, Streicher EM, Kewley C, Jordaan AM, Spuy van der GD, Bosman M, Louw H, Murray M, Young D, van Helden PD, Warren RM: Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis. 2007, 11: 195-201.PubMed
31.
go back to reference Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E: Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis. 2008, 12: 99-104.PubMed Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E: Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis. 2008, 12: 99-104.PubMed
Metadata
Title
Evidence for waning of latency in a cohort study of tuberculosis
Authors
Harald G Wiker
Tehmina Mustafa
Gunnar A Bjune
Morten Harboe
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-37

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue